Literature DB >> 24412351

Systematic review of human papillomavirus vaccine coadministration.

Alinea S Noronha1, Lauri E Markowitz1, Eileen F Dunne2.   

Abstract

Human papillomavirus (HPV) vaccination is recommended in early adolescence, at an age when other vaccines are also recommended. Administration of multiple vaccines during one visit is an opportunity to improve uptake of adolescent vaccines. We conducted a systematic review of safety and immunogenicity of HPV vaccines coadministered with other vaccines. Our review included 9 studies, 4 of quadrivalent HPV vaccine and 5 of bivalent HPV vaccine; coadministered vaccines included: meningococcal conjugate, hepatitis A, hepatitis B, combined hepatitis A and B, tetanus, diphtheria, acellular pertussis, and inactivated poliovirus vaccines. Studies varied in methods of data collection and measurement of immunogenicity and safety. Noninferiority of immune response and an acceptable safety profile were demonstrated when HPV vaccine was coadministered with other vaccines. Published by Elsevier Ltd.

Entities:  

Keywords:  Coadministration; Concomitant; HPV vaccination; Immunogenicity; Safety

Mesh:

Substances:

Year:  2014        PMID: 24412351     DOI: 10.1016/j.vaccine.2013.12.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

Review 1.  Present challenges in cervical cancer prevention: Answers from cost-effectiveness analyses.

Authors:  Mireia Diaz; Silvia de Sanjosé; F Xavier Bosch; Laia Bruni
Journal:  Rep Pract Oncol Radiother       Date:  2018-04-26

Review 2.  Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine.

Authors:  Zhigang Zhang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 3.  Making HPV vaccination available to girls everywhere.

Authors:  Austin M Oberlin; Lisa Rahangdale; Lameck Chinula; Nurain M Fuseini; Carla J Chibwesha
Journal:  Int J Gynaecol Obstet       Date:  2018-09-12       Impact factor: 3.561

4.  School Entry Requirements and Coverage of Nontargeted Adolescent Vaccines.

Authors:  Jennifer L Moss; Paul L Reiter; Young K Truong; Barbara K Rimer; Noel T Brewer
Journal:  Pediatrics       Date:  2016-11-08       Impact factor: 7.124

Review 5.  The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.

Authors:  Yvonne Deleré; Ole Wichmann; Stefanie J Klug; Marianne van der Sande; Martin Terhardt; Fred Zepp; Thomas Harder
Journal:  Dtsch Arztebl Int       Date:  2014-09-01       Impact factor: 5.594

6.  Concomitant Adolescent Vaccination in the U.S., 2007-2012.

Authors:  Jennifer L Moss; Paul L Reiter; Noel T Brewer
Journal:  Am J Prev Med       Date:  2016-06-30       Impact factor: 5.043

7.  Summer Peaks in Uptake of Human Papillomavirus and Other Adolescent Vaccines in the United States.

Authors:  Jennifer L Moss; Paul L Reiter; Barbara K Rimer; Kurt M Ribisl; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-16       Impact factor: 4.254

Review 8.  Assessing an intervention to increase knowledge related to cervical cancer and the HPV vaccine.

Authors:  Marvella E Ford; Kimberly Cannady; Georges J Nahhas; Kendrea D Knight; Courtney Chavis; Brittney Crawford; Angela M Malek; Erica Martino; Starr Frazier; Antiqua Gathers; Claudia Lawton; Kathleen B Cartmell; John S Luque
Journal:  Adv Cancer Res       Date:  2020-03-12       Impact factor: 6.242

Review 9.  Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2014-07       Impact factor: 11.431

Review 10.  Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

Authors:  Marc Arbyn; Lan Xu; Cindy Simoens; Pierre Pl Martin-Hirsch
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.